News

ACQUISITION

Dannex Limited is the majority shareholder in both Starwin Products (71.33%) and Ayrton Drug (53.47%) Dannex intends to merge the three companies into one formidable company, both operationally and legally. The purpose of the merger is to create synergies and scale to be able to compete effectively and profitably in Ghana and West Africa. The best of the three companies would be put together to produce high quality and value for money medicines that would meet customer and consumer needs.